Interim 2025/26 influenza vaccine effectiveness estimates with immuno-epidemiological considerations for A(H3N2) subclade K protection, Canada, January 2026

In interim 2025/26 analyses, the Canadian Sentinel Practitioner Surveillance Network estimates influenza vaccine reduced the risk of medically-attended acute respiratory illness due to predominant influenza A(H3N2) viruses, including antigenically distinct subclade K, by about 40% relative to unvacc...

Celý popis

Podrobná bibliografie

Hlavní autor:	Danuta M Skowronski
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	European Centre for Disease Prevention and Control 2026-02-01
Edice:	Eurosurveillance
Témata:	imprinting antigenic characterization Influenza test-negative design A(H1N1)pdm09 A(H3N2)
On-line přístup:	https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2026.31.5.2600068
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!